These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12499470)

  • 41. Mammography coding and reimbursement.
    Odle TG
    Radiol Technol; 2003; 74(5):385-404; quiz 405-12. PubMed ID: 12800568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Current indications of polyvalent immunoglobulins].
    Magy L
    Bull Acad Natl Med; 2012 Jan; 196(1):49-60; discussion 61. PubMed ID: 23259332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacologic agents for pediatric neuroimmune disorders.
    Golumbek P
    Semin Pediatr Neurol; 2010 Dec; 17(4):245-53. PubMed ID: 21183131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia.
    Alangari AA; Abutaleb MH; Albarraq AA; Al-Dhowailie AA
    Saudi Med J; 2008 Jul; 29(7):975-9. PubMed ID: 18626524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review.
    Liu CH; Chiu LC; Lee CC; Chan TM
    Front Immunol; 2023; 14():1240089. PubMed ID: 37809102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous Immunoglobulin in the Treatment of Hematologic Disorders in Pediatrics.
    Villanueva G; de Jong JL; McNeer JL
    Pediatr Ann; 2017 Jan; 46(1):e13-e18. PubMed ID: 28079913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous immunoglobulin in neurological disease: a specialist review.
    Wiles CM; Brown P; Chapel H; Guerrini R; Hughes RA; Martin TD; McCrone P; Newsom-Davis J; Palace J; Rees JH; Rose MR; Scolding N; Webster AD
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):440-8. PubMed ID: 11909900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
    Hahn AF
    Neurology; 1998 Dec; 51(6 Suppl 5):S16-21. PubMed ID: 9851725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).
    Straubel D; Thielitz A; Reinhold A; Grüngreiff K; Reinhold D
    J Immunol Res; 2018; 2018():5982169. PubMed ID: 30356433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reimbursement: current status and future outlook.
    Bailes JS
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):118-22. PubMed ID: 8091237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.
    Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P
    Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of intravenous immunoglobulin therapy in a case of idiopathic recurrent brachial and lumbosacral plexopathy].
    Inoue C; Hayashi A; Yoshizawa T; Sato A; Shoji S
    Rinsho Shinkeigaku; 1999 Jun; 39(6):661-4. PubMed ID: 10502994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives].
    Wintzell A; Eriksson T; Lundgren A; Petersson J
    Lakartidningen; 2008 May 21-27; 105(21):1571-5. PubMed ID: 18574994
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of intravenous immunoglobulin G (IVIG).
    Looney RJ; Huggins J
    Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune mediated neuropathies--an update on therapeutic strategies.
    Czaplinski A; Steck AJ
    J Neurol; 2004 Feb; 251(2):127-37. PubMed ID: 14991345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.
    Ruiz-Antorán B; Agustí Escasany A; Vallano Ferraz A; Danés Carreras I; Riba N; Mateu Escudero S; Costa J; Sánchez Santiago MB; Laredo L; Durán Quintana JA; Castillo JR; Abad-Santos F; Payares Herrera C; Sádaba Díaz de Rada B; Gómez Ontañón E
    Eur J Clin Pharmacol; 2010 Jun; 66(6):633-41. PubMed ID: 20204337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.